文献速递细胞病理与分子病理神经与头颈病理

甲状腺Hürthle细胞病变:进展与挑战

Hürthle cell lesions of the thyroid: Progress made and challenges remaining.
PubMed 文献 · Cancer Cytopathol · 2020-10-27

甲状腺Hürthle细胞为主的细针穿刺(FNA)在常规实践中常见,但诊断准确困难且观察者间差异显著,因Hürthle细胞见于非肿瘤至侵袭性恶性肿瘤。近十年对Hürthle细胞肿瘤分子发病机制及分子检测应用于细胞学材料的认识大幅增加,本综述提供诊断挑战背景并总结诊断工具新进展。

要点

  • Hürthle细胞为主FNA诊断准确困难且观察者间差异显著。
  • Hürthle细胞见于非肿瘤至侵袭性恶性肿瘤,鉴别困难。
  • 近十年分子检测应用于细胞学材料取得进展。

核心结论

  • Hürthle细胞病变的细胞形态学诊断局限预计持续存在,但分子检测进展显著。

研究设计与样本

  • 综述,总结Hürthle细胞病变诊断挑战及诊断工具新进展。

主要发现

  • Hürthle细胞为主FNA诊断准确困难且观察者间差异显著。
  • Hürthle细胞广泛存在于非肿瘤至侵袭性恶性肿瘤。
  • 近十年分子发病机制知识及分子检测应用大幅增加。

临床怎么用

  • 对Hürthle细胞为主FNA,可结合分子检测辅助诊断。

局限性

  • 细胞形态学诊断局限预计持续存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hürthle cell-predominant thyroid fine needle aspirations (FNA) are encountered frequently in routine practice, yet they are often challenging to diagnose accurately and are associated with significant interobserver variability. This is largely due to the ubiquity of Hürthle cells in thyroid pathology, ranging from nonneoplastic conditions to aggressive malignancies. Although limitations in cytomorphologic diagnoses likely will remain for the foreseeable future, our knowledge of the molecular pathogenesis of Hürthle cell neoplasia and application of molecular testing to cytologic material have increased dramatically within the past decade. This review provides context behind the challenges in diagnosis of Hürthle cell lesions and summarizes the more recent advances in diagnostic tools.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wong KS, Angell TE, Barletta JA, et al. Hürthle cell lesions of the thyroid: Progress made and challenges remaining. Cancer Cytopathol. 2020. PMID: 33108684. doi:10.1002/cncy.22375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。